TheraRadar
Data updated: May 26, 2026

ZOSYN IN PLASTIC CONTAINER (piperacillin sodium)

Infectious Disease Approved 1998-02-24

ZOSYN IN PLASTIC CONTAINER is indicated for the treatment of Intra-abdominal Infections; Nosocomial Pneumonia; Skin and Skin Structure Infections; Female Pelvic Infections; Community-Acquired Pneumonia; Appendicitis; Peritonitis.

Source: FDA Label • Baxter
4
Indications
--
Phase 3 Trials
28
Years on Market

Details

Status
Prescription
First Approved
1998-02-24
Routes
INJECTION
Dosage Forms
INJECTABLE

Companies

Active Ingredient: PIPERACILLIN SODIUM , TAZOBACTAM SODIUM

ZOSYN IN PLASTIC CONTAINER Approval History

1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
114 FDA actions from 1998 to 2024 · 3 indication expansions
Dec 2024 SUPPL
Label · Labeling
Nov 2024 SUPPL
Label · Labeling
May 2024 SUPPL
Label · Labeling

What ZOSYN IN PLASTIC CONTAINER Treats

7 indications

ZOSYN IN PLASTIC CONTAINER is approved for 7 conditions since its original approval in 1998. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Intra-abdominal Infections
  • Nosocomial Pneumonia
  • Skin and Skin Structure Infections
  • Female Pelvic Infections
  • Community-Acquired Pneumonia
  • Appendicitis
  • Peritonitis
Source: FDA Label

ZOSYN IN PLASTIC CONTAINER Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to ZOSYN IN PLASTIC CONTAINER

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

PIPERACILLIN
PIPERACILLIN SODIUM
7 shared
ISTITUTO BIO ITA SPA
Shared indications:
PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
PIPERACILLIN SODIUM
7 shared
B BRAUN MEDICAL
Shared indications:
ERTAPENEM SODIUM
ERTAPENEM SODIUM
3 shared
SAVIOR LIFETEC CORP
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ZOSYN IN PLASTIC CONTAINER FDA Label Details

Indications & Usage

FDA Label (PDF)

ZOSYN IN PLASTIC CONTAINER is indicated for the treatment of Intra-abdominal Infections; Nosocomial Pneumonia; Skin and Skin Structure Infections; Female Pelvic Infections; Community-Acquired Pneumonia; Appendicitis; Peritonitis.

Track ZOSYN IN PLASTIC CONTAINER with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.